HomeOwner SearchCategory Search
The Effect of Mutating RUNX1 Binding Site on HIV-1 Replication and Novel HIV-1 Latency Reversal through Using Clinically Prescribed Benzodiazepines
Visit USCO
hero image
Text Registration
Copyright Title

The Effect of Mutating RUNX1 Binding Site on HIV-1 Replication and Novel HIV-1 Latency Reversal through Using Clinically Prescribed Benzodiazepines

Status

Published

on 29 Apr 2019
Year of Creation
2019
Copyright Claimant
Weam Elbezanti
Registration Number
TX0008738415
on 29 Apr 2019

Copyright Summary


The U.S. Copyright record (Registration Number: TX0008738415) dated 29 Apr 2019, pertains to an electronic file (eService) titled "The Effect of Mutating RUNX1 Binding Site on HIV-1 Replication and Novel HIV-1 Latency Reversal through Using Clinically Prescribed Benzodiazepines" created in 2019. The copyright holder is Weam Elbezanti, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Weam Elbezanti.

Copyright Details


Copyright Claimant
Weam Elbezanti

Application Details


Registration Number
TX0008738415
Registration Date
4/29/2019
Year of Creation
2019
Agency Marc Code
DLC-CO
Record Status
New
Physical Description
Electronic file (eService)
First Publication Nation
United States

Personal Authors


Notes


Rights Note: Mark Dill, ProQuest-CSA, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600, disspub@proquest.com

Statements


Application Title Statement: The Effect of Mutating RUNX1 Binding Site on HIV-1 Replication and Novel HIV-1 Latency Reversal through Using Clinically Prescribed Benzodiazepines
Author Statement: Weam Othman Elbezanti Citizenship: not known Authorship: text
Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

© 2024 reserved by Trademarkia
Show terms & conditions